In a study led by a multinational team of experts, researchers at National Jewish Health and their collaborators in Colorado, ...

Sarcoidosis is a systemic inflammatory disorder of unknown etiology, characterized by the formation of noncaseating granulomas, multisystem involvement, intrathoracic (pulmonary and lymph node ...

A woman in her 40s presented with a one month history of swelling and tenderness of the ears (fig 1), along with pain in her palms and fingers, and mild chest tightness. She had no history of chronic ...

Topline data from Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis on track for the third quarter of 2025.

The US remains the largest pulmonary sarcoidosis market, both in terms of patient pool and market value. This dominance is attributed to higher diagnosis rates, advanced healthcare infrastructure ...

Abortion bans have affected US pulmonary and critical care physicians, resulting in care delays and restrictions, especially for low-income patients.

“As a sarcoidosis patient and storyteller, I’ve heard firsthand how this disease frustrates and isolates people. FSR is moving the needle in awareness and research. I hope to guide the ...

Beyond journalism, John is an active community advocate and member of FSR's Patient Advisory Committee. He is the creator and host of The FSR Sarc Fighter Podcast, where he raises awareness by sharing ...